tolonium chloride


Also found in: Wikipedia.

to·lo·ni·um chlor·ide

(tō-lō'nē-ŭm klōr'īd),
The medicinal grade of toluidine blue O, used as an antiheparin compound.

tolonium chloride

see toluidine blue.
Mentioned in ?
References in periodicals archive ?
5 percent tolonium chloride solution, one bottle of 6.
OraBlu Oral Lesion Marking System
Use of meta-analysis to evaluate tolonium chloride in oral cancer screening.
Diagnostic devices for detecting oral cancer
We are also very excited about the FDA's recent clearance to market our Zila(R) Tolonium Chloride marking product and we believe that this clearance will be beneficial to our efforts to build the market for ViziLite.
ZILA FISCAL 2005 2ND QTR NET REVENUES DECREASE 2%
The unit will operate as a comprehensive research, development and licensing business specializing in precancer and cancer detection through Zila tolonium chloride, a patented technology.
Zila is gearing up efforts in cancer detection arena. (Biotechnology)
For heavy smokers, dentists might recommend a yearly screening process where the patient is asked to gargle tolonium chloride, a dye which will colour suspect patches blue.
Health: Time to get more oral about a silent cancer; Lung cancer may be the Cinderella disease as far as research funding is concerned, but oral cancer is one branch of the disease where less is heard - despite incidence growing at an alarming rate. Andrew Davies looks at how dentists are contributing to the fight against a disease where early detection can save lives
Zila already holds several patents and has additional patent applications pending for the use of a specific dye, toluidine blue 0, or tolonium chloride, for the detection of oral cancer.
Zila issued additional patent related to the OraTest oral cancer detection product
Two common photosensitizers are tolonium chloride and methylene blue.
Successful laser therapy takes Planning
This new reporting group consists of the OraTest product, expenses related to clinical trials for OraTest, and the Tolonium Chloride technology.
ZILA REPORTS 20.7 PERCENT INCREASE IN REVENUE
During the third quarter of fiscal 2002, the company invested $1,018,000 in the OraTest(R)/Zila(R) Tolonium Chloride program, which encompasses the OraTest oral cancer detection product Phase III clinical trial, other OraTest research, and the broad Zila Tolonium Chloride research, development and manufacturing effort.
ZILA REPORTS HIGHER NET REVENUES FOR 3RD QTR FISCAL '02

Medical browser ?
Full browser ?